LEPTOSPIROSIS MARKET ANALYSIS

Regional Analysis

Global Leptospirosis Market- Regional Analysis

Among regions, Africa is estimated to hold a dominant position in the global leptospirosis market over the forecast period owing to the increasing prevalence of leptospirosis in the region. For instance, on July 14, 2022, according to the World Health Organization (WHO), the Ministry of Health (MoH) of the United Republic of Tanzania, Africa, notified WHO of 13 cases of leptospirosis. The first two cases were presented to a health center located in Ruangwa District, Lindi Region, on July 5 and 7,2022,  with symptoms of fever, bleeding from the nose, headache, and general body weakness. Thus, the demand for the drug required for leptospirosis treatment is going to rise in the near future, which is expected to drive the growth of the market over the forecast period.

• North America: U.S. and Canada
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Middle East: GCC Countries, Israel, and Rest of Middle East
• Africa: South Africa, North Africa, and Central Africa